Where Do We Actually Stand? Casgevy, Cancer, Limits
CRISPR and the Gene Revolution
Casgevy fully explained ($2.2M price tag). Cancer immunotherapy trials. The fundamental limits. Anchor resolved.
1
Learning Material
5 pagesLesson 6 — Where Do We Actually Stand?
Understanding the Complex: CRISPR and the Gene Revolution
The anchor example, completed:
Victoria Gray received Casgevy in 2023. Her blood stem cells were removed, edited with CRISPR to reactivate fetal hemoglobin, and returned. The pain crises stopped. The edit is in her blood cells only. Her children will not inherit it. The treatment cost $2.2 million in the United States.
That sentence contains both the triumph and the unresolved tension of where CRISPR stands right now.